PRCT logo

PROCEPT BioRobotics Corporation (PRCT)

Profile

Full Name

PROCEPT BioRobotics Corporation

Ticker

NASDAQ: PRCT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

September 15, 2021

Indexes

Not included

Website

https://www.procept-biorobotics.com

Employees

756

Key Details

Price

$36.26(1.53%)

Market Cap

$2.03B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$224.50M(64.84% YoY)

Annual EPS

-$1.75(21.74% YoY)

PE Ratio

-

Next earnings date

Mar 2, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $36.26
    PRCT price is $36.26

    30-Day Relative Volume

    0.85
    PRCT 30-day relative volume is 0.85

    Price Performance

    Price 1-Day Change

    +1.53%
    PRCT price is up +1.53% today

    Price YTD Change

    -54.97%
    PRCT price is down -54.97% since January 1st

    Price 1-Year Change

    -59.99%
    PRCT price is down -59.99% year-on-year

    Price 3-Year Change

    -15.31%
    PRCT price is down -15.31% over the past 3 years

    Price Range

    Price All-Time High

    $103.81
    PRCT price is currently -65.08% below its historical high of $103.81

    Price 3-Year Low

    $24.83
    PRCT price is currently +46.01% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.03B
    PRCT market cap is $2.03 billion

    Market Cap 3-Year Change

    +5.82%
    PRCT market cap is up +5.82% over the past 3 years

    Market Cap All-Time High

    $5.38B
    PRCT market cap is currently -62.35% below its historical high of $5.38 billion

    Market Cap Sector Percentile

    79.62%
    PRCT market cap is higher than 79.62% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.28%
    PRCT shares outstanding is up +3.28% year-on-year

    Shares Outstanding 3-Year Change

    +24.95%
    PRCT shares outstanding is up +24.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.01
    PRCT beta is 1.01

    200-day SMA

    $47.65
    PRCT price is currently -23.92% below its 200-day simple moving average

    50-day SMA

    $33.05
    PRCT price is currently +9.69% above its 50-day simple moving average

    14-Day RSI

    60.55
    PRCT 14-day relative strength index is 60.55

    Volume

    0.85
    PRCT 30-day relative volume is 0.85

    ATR

    $1.86
    PRCT average true range is $1.86

    10-day Historical Volatility

    84.21%
    PRCT 10-day historical volatility is 84.21%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $224.50M
    PRCT annual revenue is $224.50 million

    Revenue Analysts Estimate

    $326.47M
    PRCT annual revenue is currently -31.23% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +64.84%
    PRCT annual revenue is up +64.84% year-on-year

    Revenue Sector Percentile

    75.23%
    PRCT annual revenue is higher than 75.23% of companies in Healthcare sector

    EPS

    EPS

    -$1.75
    PRCT annual earnings per share is -$1.75

    EPS Analysts Estimate

    -$1.51
    PRCT annual earnings per share is currently -16.14% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +21.74%
    PRCT annual earnings per share is up +21.74% year-on-year

    EPS Sector Percentile

    41.18%
    PRCT annual earnings per share is higher than 41.18% of companies in Healthcare sector

    Profit

    Gross Profit

    $137.10M
    PRCT annual gross profit is $137.10 million

    Gross Margin

    61.07%
    PRCT annual gross profit margin is 61.07%

    Operating Profit

    -$96.61M
    PRCT annual operating income is -$96.61 million

    Operating Margin

    -43.04%
    PRCT annual operating profit margin is -43.04%

    Net Income

    -$91.41M
    PRCT annual net profit is -$91.41 million

    Net Margin

    -40.72%
    PRCT annual net profit margin is -40.72%

    Expenses

    Total Expenses

    $321.11M
    PRCT annual total expenses is $321.11 million

    Operating Expenses

    $233.71M
    PRCT annual total operating expenses is $233.71 million

    Cost Of Goods Sold

    $87.40M
    PRCT annual cost of goods sold is $87.40 million

    Selling, General & Administrative Expenses

    $171.41M
    PRCT annual SG&A is $171.41 million

    Depreciation & Amortization

    $5.23M
    PRCT annual D&A is $5.23 million

    Interest Expense

    $4.18M
    PRCT annual interest expense is $4.18 million

    Income Tax

    $0.00
    PRCT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$87.23M
    PRCT annual earnings before interest & taxes is -$87.23 million

    EBITDA

    -$87.23M
    PRCT annual EBITDA is -$87.23 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $534.02M
    PRCT annual total assets is $534.02 million

    Non Current Assets

    $52.17M
    PRCT annual long term assets is $52.17 million

    Current Assets

    $481.84M
    PRCT annual total current assets is $481.84 million

    Cash and Cash Equivalents

    $333.73M
    PRCT annual cash & cash equivalents is $333.73 million

    Accounts Receivable

    $83.50M
    PRCT annual accounts receivable is $83.50 million

    Inventory

    $56.17M
    PRCT annual inventory is $56.17 million

    Liabilities

    Total Liabilities

    $131.80M
    PRCT annual total liabilities is $131.80 million

    Long Term Liabilities

    $78.66M
    PRCT annual total long term liabilities is $78.66 million

    Current Liabilities

    $53.13M
    PRCT annual current liabilities is $53.13 million

    Accounts Payable

    $10.03M
    PRCT annual accounts payable is $10.03 million

    Debt

    Total Debt

    $80.25M
    PRCT annual total debt is $80.25 million

    Total Debt 1-Year Change

    +1.32%
    PRCT annual total debt is up +1.32% year-on-year

    Long Term Debt

    $78.34M
    PRCT annual long term debt is $78.34 million

    Short Term Debt

    $1.91M
    PRCT annual short term debt is $1.91 million

    Equity & Capital

    Shareholders Equity

    $402.22M
    PRCT annual stockholders equity is $402.22 million

    Book Value

    $402.22M
    PRCT annual book value is $402.22 million

    Retained Earnings

    -$545.99M
    PRCT annual retained earnings is -$545.99 million

    Working Capital

    $428.71M
    PRCT annual working capital is $428.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$99.21M
    PRCT annual cash from operations is -$99.21 million

    Cash From Operations 1-Year Change

    +8.14%
    PRCT annual cash from operations is up +8.14% year-on-year

    Cash From Investing

    -$4.41M
    PRCT annual cash from investing is -$4.41 million

    Cash From Investing 1-Year Change

    +82.51%
    PRCT annual cash from investing is up +82.51% year-on-year

    Cash From Financing

    $180.13M
    PRCT annual cash from financing is $180.13 million

    Cash From Financing 1-Year Change

    +7.35%
    PRCT annual cash from financing is up +7.35% year-on-year

    CAPEX

    CAPEX

    $4.41M
    PRCT annual capital expenditures is $4.41 million

    CAPEX 1-Year Change

    -82.51%
    PRCT annual capital expenditures is down -82.51% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$103.62M
    PRCT annual free cash flow is -$103.62 million

    Free Cash Flow 1-Year Change

    +22.21%
    PRCT annual free cash flow is up +22.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    61.07%
    PRCT annual gross profit margin is 61.07%

    Operating Margin

    -43.04%
    PRCT annual operating profit margin is -43.04%

    Net Margin

    -40.72%
    PRCT annual net profit margin is -40.72%

    ROA & ROE

    ROA

    -19.48%
    PRCT annual return on assets is -19.48%

    ROE

    -26.77%
    PRCT annual return on equity is -26.77%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    PRCT price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    PRCT price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.33
    PRCT price to book ratio is 5.33

    PB Ratio Sector Percentile

    76.5%
    PRCT price to book ratio is higher than 76.5% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    6.76
    PRCT price to sales ratio is 6.76

    PS Ratio Sector Percentile

    62.35%
    PRCT price to sales ratio is higher than 62.35% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.81B
    PRCT enterprise value is $1.81 billion

    Enterprise Value Sector Percentile

    77.73%
    PRCT enterprise value is higher than 77.73% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -20.96
    PRCT EV/EBITDA is -20.96

    EV/EBITDA Sector Percentile

    6.98%
    PRCT EV/EBITDA is higher than 6.98% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    9.07
    PRCT annual current ratio is 9.07

    Quick Ratio

    8.01
    PRCT annual quick ratio is 8.01

    Leverage

    Debt To Equity

    0.13
    PRCT annual debt to equity ratio is 0.13

    Interest Coverage Ratio

    -20.85
    PRCT annual interest coverage ratio is -20.85

    Risk & Stability

    F-Score

    5
    PRCT piotroski f-score is 5

    Altman Z-Score

    8.64
    PRCT altman z-score is 8.64

    Analyst ratings

    Recent major analysts updates

    Dec 8, 25 B of A Securities
    Neutral
    Dec 2, 25 Morgan Stanley
    Overweight
    Nov 5, 25 Wells Fargo
    Overweight
    Nov 5, 25 TD Cowen
    Buy
    Nov 5, 25 Piper Sandler
    Overweight
    Oct 15, 25 Truist Securities
    Buy
    Sep 16, 25 BTIG
    Neutral
    Sep 2, 25 Oppenheimer
    Outperform
    Aug 7, 25 Wells Fargo
    Overweight
    Aug 7, 25 Piper Sandler
    Overweight

    Institutional Ownership

    Screeners with PRCT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for PROCEPT BioRobotics Corporation?
    • Does PROCEPT BioRobotics Corporation pay dividends?
    • What sector is PROCEPT BioRobotics Corporation in?
    • What industry is PROCEPT BioRobotics Corporation in?
    • What country is PROCEPT BioRobotics Corporation based in?
    • When did PROCEPT BioRobotics Corporation go public?
    • Is PROCEPT BioRobotics Corporation in the S&P 500?
    • Is PROCEPT BioRobotics Corporation in the NASDAQ 100?
    • Is PROCEPT BioRobotics Corporation in the Dow Jones?
    • When was PROCEPT BioRobotics Corporation's last earnings report?
    • When does PROCEPT BioRobotics Corporation report earnings?

    What is the ticker symbol for PROCEPT BioRobotics Corporation?

    The ticker symbol for PROCEPT BioRobotics Corporation is NASDAQ:PRCT

    Does PROCEPT BioRobotics Corporation pay dividends?

    No, PROCEPT BioRobotics Corporation does not pay dividends

    What sector is PROCEPT BioRobotics Corporation in?

    PROCEPT BioRobotics Corporation is in the Healthcare sector

    What industry is PROCEPT BioRobotics Corporation in?

    PROCEPT BioRobotics Corporation is in the Medical Devices industry

    What country is PROCEPT BioRobotics Corporation based in?

    PROCEPT BioRobotics Corporation is headquartered in United States

    When did PROCEPT BioRobotics Corporation go public?

    PROCEPT BioRobotics Corporation's initial public offering (IPO) was on September 15, 2021

    Is PROCEPT BioRobotics Corporation in the S&P 500?

    No, PROCEPT BioRobotics Corporation is not included in the S&P 500 index

    Is PROCEPT BioRobotics Corporation in the NASDAQ 100?

    No, PROCEPT BioRobotics Corporation is not included in the NASDAQ 100 index

    Is PROCEPT BioRobotics Corporation in the Dow Jones?

    No, PROCEPT BioRobotics Corporation is not included in the Dow Jones index

    When was PROCEPT BioRobotics Corporation's last earnings report?

    PROCEPT BioRobotics Corporation's most recent earnings report was on November 4, 2025

    When does PROCEPT BioRobotics Corporation report earnings?

    The next expected earnings date for PROCEPT BioRobotics Corporation is March 2, 2026
    On this page